Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment

Vascul Pharmacol. 2024 Jun:155:107295. doi: 10.1016/j.vph.2024.107295.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Chronic Disease
  • Enzyme Activators / pharmacology
  • Enzyme Activators / therapeutic use
  • Etiocholanolone / analogs & derivatives
  • Etiocholanolone / pharmacology
  • Etiocholanolone / therapeutic use
  • Heart Failure* / drug therapy
  • Heart Failure* / enzymology
  • Heart Failure* / metabolism
  • Heart Failure* / physiopathology
  • Humans
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases* / metabolism

Substances

  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Istaroxime
  • Etiocholanolone
  • Enzyme Activators